vs

Side-by-side financial comparison of FirstEnergy (FE) and TENET HEALTHCARE CORP (THC). Click either name above to swap in a different company.

TENET HEALTHCARE CORP is the larger business by last-quarter revenue ($5.5B vs $3.8B, roughly 1.5× FirstEnergy). TENET HEALTHCARE CORP runs the higher net margin — 11.7% vs -1.3%, a 12.9% gap on every dollar of revenue. On growth, FirstEnergy posted the faster year-over-year revenue change (19.6% vs 9.0%). TENET HEALTHCARE CORP produced more free cash flow last quarter ($367.0M vs $-30.0M). Over the past eight quarters, FirstEnergy's revenue compounded faster (7.5% CAGR vs 1.5%).

FirstEnergy Corp. is an electric utility headquartered in Akron, Ohio. It was established when Ohio Edison merged with Centerior Energy in 1997.

Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International (USPI), the company operates 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients.

FE vs THC — Head-to-Head

Bigger by revenue
THC
THC
1.5× larger
THC
$5.5B
$3.8B
FE
Growing faster (revenue YoY)
FE
FE
+10.6% gap
FE
19.6%
9.0%
THC
Higher net margin
THC
THC
12.9% more per $
THC
11.7%
-1.3%
FE
More free cash flow
THC
THC
$397.0M more FCF
THC
$367.0M
$-30.0M
FE
Faster 2-yr revenue CAGR
FE
FE
Annualised
FE
7.5%
1.5%
THC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FE
FE
THC
THC
Revenue
$3.8B
$5.5B
Net Profit
$-49.0M
$644.0M
Gross Margin
Operating Margin
-0.6%
15.4%
Net Margin
-1.3%
11.7%
Revenue YoY
19.6%
9.0%
Net Profit YoY
-118.8%
12.6%
EPS (diluted)
$-0.08
$4.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FE
FE
THC
THC
Q4 25
$3.8B
$5.5B
Q3 25
$4.1B
$5.3B
Q2 25
$3.4B
$5.3B
Q1 25
$3.8B
$5.2B
Q4 24
$3.2B
$5.1B
Q3 24
$3.7B
$5.1B
Q2 24
$3.3B
$5.1B
Q1 24
$3.3B
$5.4B
Net Profit
FE
FE
THC
THC
Q4 25
$-49.0M
$644.0M
Q3 25
$441.0M
$579.0M
Q2 25
$268.0M
$522.0M
Q1 25
$360.0M
$622.0M
Q4 24
$261.0M
$572.0M
Q3 24
$419.0M
$681.0M
Q2 24
$45.0M
$477.0M
Q1 24
$253.0M
$2.3B
Operating Margin
FE
FE
THC
THC
Q4 25
-0.6%
15.4%
Q3 25
20.0%
16.8%
Q2 25
19.1%
15.6%
Q1 25
20.0%
18.1%
Q4 24
19.3%
16.2%
Q3 24
19.5%
21.3%
Q2 24
12.9%
14.9%
Q1 24
18.6%
61.2%
Net Margin
FE
FE
THC
THC
Q4 25
-1.3%
11.7%
Q3 25
10.6%
10.9%
Q2 25
7.9%
9.9%
Q1 25
9.6%
11.9%
Q4 24
8.2%
11.3%
Q3 24
11.2%
13.3%
Q2 24
1.4%
9.3%
Q1 24
7.7%
43.5%
EPS (diluted)
FE
FE
THC
THC
Q4 25
$-0.08
$4.22
Q3 25
$0.76
$3.86
Q2 25
$0.46
$3.14
Q1 25
$0.62
$4.27
Q4 24
$0.45
$3.79
Q3 24
$0.73
$4.89
Q2 24
$0.08
$2.64
Q1 24
$0.44
$21.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FE
FE
THC
THC
Cash + ST InvestmentsLiquidity on hand
$57.0M
$2.9B
Total DebtLower is stronger
$25.5B
$13.1B
Stockholders' EquityBook value
$12.5B
$4.2B
Total Assets
$55.9B
$29.7B
Debt / EquityLower = less leverage
2.04×
3.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FE
FE
THC
THC
Q4 25
$57.0M
$2.9B
Q3 25
$1.4B
$3.0B
Q2 25
$569.0M
$2.6B
Q1 25
$132.0M
$3.0B
Q4 24
$111.0M
$3.0B
Q3 24
$439.0M
$4.1B
Q2 24
$60.0M
$2.9B
Q1 24
$888.0M
$2.5B
Total Debt
FE
FE
THC
THC
Q4 25
$25.5B
$13.1B
Q3 25
$25.5B
$13.1B
Q2 25
$23.7B
$13.1B
Q1 25
$21.2B
$13.1B
Q4 24
$22.5B
$13.1B
Q3 24
$21.6B
$12.8B
Q2 24
$20.8B
$12.8B
Q1 24
$21.7B
$12.8B
Stockholders' Equity
FE
FE
THC
THC
Q4 25
$12.5B
$4.2B
Q3 25
$12.8B
$4.0B
Q2 25
$12.9B
$3.7B
Q1 25
$12.6B
$4.2B
Q4 24
$12.5B
$4.2B
Q3 24
$12.4B
$3.8B
Q2 24
$12.5B
$3.5B
Q1 24
$12.4B
$3.5B
Total Assets
FE
FE
THC
THC
Q4 25
$55.9B
$29.7B
Q3 25
$55.9B
$29.4B
Q2 25
$54.2B
$28.7B
Q1 25
$52.8B
$29.2B
Q4 24
$52.0B
$28.9B
Q3 24
$50.8B
$29.4B
Q2 24
$51.0B
$29.3B
Q1 24
$51.3B
$28.9B
Debt / Equity
FE
FE
THC
THC
Q4 25
2.04×
3.10×
Q3 25
1.99×
3.26×
Q2 25
1.85×
3.49×
Q1 25
1.69×
3.13×
Q4 24
1.81×
3.14×
Q3 24
1.74×
3.33×
Q2 24
1.67×
3.67×
Q1 24
1.75×
3.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FE
FE
THC
THC
Operating Cash FlowLast quarter
$1.1B
$731.0M
Free Cash FlowOCF − Capex
$-30.0M
$367.0M
FCF MarginFCF / Revenue
-0.8%
6.6%
Capex IntensityCapex / Revenue
30.7%
6.6%
Cash ConversionOCF / Net Profit
1.14×
TTM Free Cash FlowTrailing 4 quarters
$-1.0B
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FE
FE
THC
THC
Q4 25
$1.1B
$731.0M
Q3 25
$845.0M
$1.1B
Q2 25
$1.1B
$936.0M
Q1 25
$637.0M
$815.0M
Q4 24
$1.0B
$-331.0M
Q3 24
$775.0M
$1.0B
Q2 24
$1.1B
$747.0M
Q1 24
$-40.0M
$586.0M
Free Cash Flow
FE
FE
THC
THC
Q4 25
$-30.0M
$367.0M
Q3 25
$-471.0M
$778.0M
Q2 25
$-136.0M
$743.0M
Q1 25
$-368.0M
$642.0M
Q4 24
$-250.0M
$-661.0M
Q3 24
$-229.0M
$829.0M
Q2 24
$170.0M
$602.0M
Q1 24
$-830.0M
$346.0M
FCF Margin
FE
FE
THC
THC
Q4 25
-0.8%
6.6%
Q3 25
-11.4%
14.7%
Q2 25
-4.0%
14.1%
Q1 25
-9.8%
12.3%
Q4 24
-7.9%
-13.0%
Q3 24
-6.1%
16.2%
Q2 24
5.2%
11.8%
Q1 24
-25.3%
6.4%
Capex Intensity
FE
FE
THC
THC
Q4 25
30.7%
6.6%
Q3 25
31.7%
5.3%
Q2 25
36.0%
3.7%
Q1 25
26.7%
3.3%
Q4 24
40.7%
6.5%
Q3 24
26.9%
4.2%
Q2 24
28.7%
2.8%
Q1 24
24.0%
4.5%
Cash Conversion
FE
FE
THC
THC
Q4 25
1.14×
Q3 25
1.92×
1.83×
Q2 25
4.04×
1.79×
Q1 25
1.77×
1.31×
Q4 24
4.00×
-0.58×
Q3 24
1.85×
1.53×
Q2 24
24.71×
1.57×
Q1 24
-0.16×
0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FE
FE

Integrated Segment$1.4B37%
Other$1.4B36%
Stand Alone Transmission Segment$466.0M12%
Industrial Customers$167.0M4%
Mid Atlantic Interstate Transmission LLC$118.0M3%
Transmission$105.0M3%
Transmission Segment$68.0M2%
Tr AIL$63.0M2%
Internal Customers$10.0M0%
Wholesale Sales$6.0M0%

THC
THC

Other$2.9B52%
Health Care Patient Service$1.4B25%
Equity Method Investment Nonconsolidated Investee Or Group Of Investees$1.2B22%
Health Care Other Sources$56.0M1%

Related Comparisons